# Nucleai

> AI-powered spatial biology technology

Business model and tags: B2B, Healthtech, Platform, Sales-led purchase, Sells to enterprises, Has in-house R&D

## About Nucleai

AI-powered spatial biology technology for precision medicine, aiding drug development, treatment decisions, and patient outcomes through collaboration with pharmaceutical companies

## Key facts

- **Industry**: Software Development
- **Company size**: 51–250 employees
- **Headquarters**: chicago, illinois, United States
- **Founded**: 2018
- **Revenue**: $7.7M – $40.6M (Tamtam estimate)
- **Website**: [nucleai.ai](https://nucleai.ai/)
- **LinkedIn**: [linkedin.com/company/nucleai-ai](https://www.linkedin.com/company/nucleai-ai)

## Nucleai at a glance

Nucleai is a B2B company in the Software Development industry, headquartered in chicago, illinois, United States.

Nucleai was founded in 2018.

Nucleai has 51–250 employees.

Nucleai's revenue is $7.7M – $40.6M (Tamtam estimate).

## Frequently asked questions about Nucleai

### What is Nucleai's revenue?

Tamtam estimates Nucleai's annual revenue at $7.7M – $40.6M.

### How many employees does Nucleai have?

Nucleai has 51–250 employees.

### Where is Nucleai headquartered?

Nucleai is headquartered in chicago, illinois, United States.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/nucleai